Beradio, Javelene Q.
HRN: 03-68-07 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
CEFUROXIME 500MG (TAB)
09/21/2022
09/28/2022
PO
500mg
Q12
T/C UTI
Waiting Final Action